Givaudan | GIVN - Sales Revenues


Givaudan reported CHF3.61B in Sales Revenues for its fiscal semester ending in December of 2025.





Sales Change Date
Air Liquide EUR 13.83B 7.04B Jun/2026
Akzo Nobel EUR 2.59B 200M Jun/2026
Anheuser-Busch USD 16.66B 1.39B Jun/2026
Arkema EUR 2.43B 250M Jun/2026
Associated British Foods GBP 9.46B 490M Mar/2026
BASF EUR 17.21B 1.19B Jun/2026
Bayer EUR 10.87B 2.54B Jun/2026
Beiersdorf EUR 2.45B 30M Jun/2026
British American Tobacco GBP 12.24B 1.26B Jun/2026
Covestro EUR 6.73B 3.82B Jun/2026
Croda International GBP 825.73M 412.23M Dec/2025
Danone EUR 7.22B 510M Jun/2026
Diageo GBP 5.59B 3.76B Dec/2025
Fresenius EUR 5.74B 140M Mar/2026
Fresenius Medical Care EUR 4.86B 250M Jun/2026
Givaudan CHF 3.61B 256M Dec/2025
Heineken EUR 14.57B 392M Dec/2025
Henkel EUR 10.09B 4.93B Dec/2025
International Flavors Fragrances USD 2.74B 150M Mar/2026
Johnson Matthey GBP 1.28B 0 Mar/2026
Kerry EUR 3.34B 540M Jun/2026
Lonza CHF 3.58B 63M Jun/2025
L'Oréal EUR 23.78B 2.2B Jun/2026
Merck EUR 5.13B 120M Mar/2026
Nestle CHF 43.11B 2.15B Jun/2026
Pernod Ricard EUR 1.94B 3.31B Mar/2026
Reckitt Benckiser GBP 7.26B 3.96B Dec/2025
SGS CHF 3.46B 1.79B Dec/2024
Sika AG CHF 5.52B 151.5M Dec/2025
Solvay EUR 1.03B 33M Jun/2026
Tate & Lyle GBP 983.99M 40.01M Mar/2026
Umicore EUR 13.92B 3.24B Jun/2026
Victrex GBP 147.1M 71.6M Mar/2026